Unique molecular signatures as a hallmark of patients with metastatic breast cancer: Implications for current treatment paradigms
暂无分享,去创建一个
R. Yelensky | V. Valero | V. Miller | F. Meric-Bernstam | R. Kurzrock | F. Janku | B. Parker | J. Wheler | M. Schwaederlé | R. Schwab | A. Tsimberidou | J. Atkins | S. Moulder | Jack J. Lee | R. Zinner | V. Subbiah | S. Fu | Jack J Lee | M. Stephens | Maria C. Schwaederlé